CryoLife, Inc. (CRY) Tops Q2 EPS by 9c; Boosts Outlook
CryoLife, Inc. (NYSE: CRY) reported Q2 EPS of $0.12, $0.09 better than the analyst estimate of $0.03. Revenue for the quarter came in at $33.2 million versus the consensus estimate of $32.79 million.
CryoLife, Inc. sees FY2012 EPS of $0.20-$0.23, versus the consensus of $0.17. CryoLife, Inc. sees FY2012 revenue of $129-$133 million, versus the consensus of $131.9 million.
CryoLife, Inc. sees FY2012 EPS of $0.20-$0.23, versus the consensus of $0.17. CryoLife, Inc. sees FY2012 revenue of $129-$133 million, versus the consensus of $131.9 million.
For earnings history and earnings-related data on CryoLife, Inc. (CRY) click here.